Stereotaxis to acquire Access Point Technologies.

Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, agreed to acquire Access Point Technologies, a privately-held Minnesota-based developer of innovative electrophysiology catheters. Financial terms were not disclosed. "Acquiring APT provides Stereotaxis with high-quality catheter development and manufacturing capabilities, and will amplify and accelerate Stereotaxis’ efforts to advance the treatment of complex arrhythmias and the adoption of robotics broadly within endovascular surgery," David Fischel, Stereotaxis Chairman and CEO.